Department of Language, Rhetoric and Media Law, Institute of Journalism and Management, Faculty of Social Sciences, Catholic University of Lublin John Paul IIPoland
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Sievers BL, Cheng MTK, Csiba K, Meng B, Gupta RK. SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”. Cell Mol Immunol. 2024;21(2):171-83.Search in Google Scholar
Wang X, Lu L, Jiang S. SARS-CoV-2 evolution from the BA.2.86 to JN.1 variants: unexpected consequences. Trends in Immunology. 2024;45(2):81-4.Search in Google Scholar
Steiner S, Kratzel A, Barut GT, Lang RM, Aguiar Moreira E, Thomann L, et al. SARS-CoV-2 biology and host interactions. Nat Rev Microbiol. 2024;22(4):206-25.Search in Google Scholar
Lam ICH, Zhang R, Man KKC, Wong CKH, Chui CSL, Lai FTT, et al. Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection. Nat Commun. 2024;15(1):1716.Search in Google Scholar
Meinhardt J, Streit S, Dittmayer C, Manitius R, Radbruch H, Heppner FL. The neurobiology of SARS-CoV-2 infection. Nat Rev Neurosci. 2024;25(1):30-42.Search in Google Scholar
Partiot E, Hirschler A, Colomb S, Lutz W, Claeys T, Delalande F, et al. Brain exposure to SARS-CoV-2 virions perturbs synaptic homeostasis. Nat Microbiol. 2024;9(5):1189-206.Search in Google Scholar
Xu C, Hou P, Li X, Xiao M, Zhang Z, Li Z, et al. Comprehensive understanding of glioblastoma molecular phenotypes: classification, characteristics, and transition. Cancer Biol Med. 2024;21(5):363-81.Search in Google Scholar
Richter V, Ernemann U, Bender B. Novel imaging approaches for glioma classification in the Era of the World Health Organization 2021 update: A scoping review. Cancers. 2024;16(10):1792.Search in Google Scholar
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: A summary. Neuro Oncol. 2021;23(8):1231-51.Search in Google Scholar
Dong J, Wang S, Xie H, Mou Y, Zhu H, Peng Y, et al. COVID-19 hospitalization increases the risk of developing glioblastoma: a bidirectional Mendelian-randomization study. Front Oncol. 2023;13:1185466.Search in Google Scholar
Diajhete R, Cisse Y, Ba M, Sall A, Ba D, Coumé M. Glioblastoma and COVID-19 in an elderly patient about a case: Review of the literature. Int J Neurol Res. 2024;6(1):01-4.Search in Google Scholar
Hu H, Wang C, Tao R, Liu B, Peng D, Chen Y, et al. Evidences of neurological injury caused by COVID-19 from glioma tissues and glioma organoids. CNS Neurosci Ther. 2024;30(6):e14822.Search in Google Scholar
Mohile NA, Blakeley JO, Gatson NTN, Hottinger AF, Lassman AB, Ney DE, et al. Urgent considerations for the neuro-oncologic treatment of patients with gliomas during the COVID-19 pandemic. Neuro Oncol. 2020;22(7):912-7.Search in Google Scholar
Yalamarty SSK, Filipczak N, Li X, Subhan MA, Parveen F, Ataide JA, et al. Mechanisms of resistance and current treatment options for Glioblastoma Multiforme (GBM). Cancers. 2023;15(7):2116.Search in Google Scholar
Bikfalvi A, Costa CA da, Avril T, Barnier JV, Bauchet L, Brisson L, et al. Challenges in glioblastoma research: focus on the tumor microenvironment. Trends Cancer. 2023;9(1):9-27.Search in Google Scholar
Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, et al. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016. Neuro-Oncology. 2019;21(Supplement_5):v1-100.Search in Google Scholar
Gatson NTN, Barnholtz-Sloan J, Drappatz J, Henriksson R, Hottinger AF, Hinoul P, et al. Tumor treating fields for glioblastoma therapy during the COVID-19 pandemic. Front Oncol. 2021;11:679702.Search in Google Scholar
Bhola S, Trisal J, Thakur V, Kaur P, Kulshrestha S, Bhatia SK, et al. Neurological toll of COVID-19. Neurol Sci. 2022;43(4):2171-86.Search in Google Scholar
Belopasov VV, Yachou Y, Samoilova EM, Baklaushev VP. The nervous system damage in COVID-19. J Clin Pract. 2020;11(2):60-80.Search in Google Scholar
Granholm AC. Long-term effects of SARS-CoV-2 in the brain: Clinical consequences and molecular mechanisms. J Clin Med. 2023;12(9):3190.Search in Google Scholar
Zhang L, Zhou L, Bao L, Liu J, Zhu H, Lv Q, et al. SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduct Target Ther. 2021;6(1):337.Search in Google Scholar
Smirnova OA, Ivanova ON, Fedyakina IT, Yusubalieva GM, Baklaushev VP, Yanvarev DV, et al. SARS-CoV-2 establishes a productive infection in hepatoma and glioblastoma multiforme cell lines. Cancers. 2023;15(3):632.Search in Google Scholar
Kyriakopoulos AM, Nigh G, McCullough PA, Seneff S. Mitogen Activated Protein Kinase (MAPK) activation, p53, and autophagy inhibition characterize the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) spike protein induced neurotoxicity. Cureus. 14(12):e32361.Search in Google Scholar
Gregory TA, Knight SR, Aaroe AE, Highsmith KN, Janatpour ZC, O’Brien BJ, et al. Accelerated tumor progression after COVID-19 infection in patients with glioblastoma: A retrospective case – control study. Neurooncol Pract. 2024;11(4):475-83.Search in Google Scholar
Lei J, Liu Y, Xie T, Yao G, Wang G, Diao B, et al. Evidence for residual SARS-CoV-2 in glioblastoma tissue of a convalescent patient. Neuroreport. 2021;32(9):771-5.Search in Google Scholar
Suarez-Meade P, Watanabe F, Ruiz-Garcia H, Rafferty SB, Moniz-Garcia D, Schiapparelli PV, et al. SARS-CoV2 entry factors are expressed in primary human glioblastoma and recapitulated in cerebral organoid models. J Neurooncol. 2023;161(1):67-76.Search in Google Scholar
Keyhanian K, Umeton RP, Mohit B, Davoudi V, Hajighasemi F, Ghasemi M. SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation. J Neuroimmunol. 2021;350:577436.Search in Google Scholar
Crunf li F, Carregari VC, Veras FP, Silva LS, Nogueira MH, Antunes ASLM, et al. Morphological, cellular, and molecular basis of brain infection in COVID-19 patients. Proc Natl Acad Sci. 2022;119(35):e2200960119.Search in Google Scholar
Hikmet F, Méar L, Edvinsson Å, Micke P, Uhlén M, Lindskog C. The protein expression profile of ACE2 in human tissues. Mol Syst Biol. 2020;16(7):e9610.Search in Google Scholar
Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: A multicenter study during the COVID-19 outbreak. Cancer Discovery. 2020;10(6):783-91.Search in Google Scholar
Li Z, Wei Y, Zhu G, Wang M, Zhang L. Cancers and COVID-19 risk: A mendelian randomization study. Cancers (Basel). 2022;14(9):2086.Search in Google Scholar
Jiang Y, Wu Q, Song P, You C. The variation of SARS-CoV-2 and advanced research on current vaccines. Front Med (Lausanne). 2021;8:806641.Search in Google Scholar
Kannan S, Shaik Syed Ali P, Sheeza A. Omicron (B.1.1.529) – variant of concern –molecular profile and epidemiology: a mini review. Eur Rev Med Pharmacol Sci. 2021;25(24):8019-22.Search in Google Scholar
Boehm E, Kronig I, Neher RA, Eckerle I, Vetter P, Kaiser L. Novel SARS-CoV-2 variants: the pandemics within the pandemic. Clin Microbiol Infect. 2021;27(8):1109-17.Search in Google Scholar
Greenberger LM, Saltzman LA, Senefeld JW, Johnson PW, DeGennaro LJ, Nichols GL. Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies. Cancer Cell. 2021;39(8):1031-3.Search in Google Scholar
Thakkar A, Pradhan K, Jindal S, Cui Z, Rockwell B, Shah AP, et al. Patterns of seroconversion for SARS-CoV2-IgG in patients with malignant disease and association with anticancer therapy. Nat Cancer. 2021;2(4):392-9.Search in Google Scholar
Sahin U, Muik A, Vogler I, Derhovanessian E, Kranz LM, Vormehr M, et al. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature. 2021;595(7868):572-7.Search in Google Scholar
Ehmsen S, Asmussen A, Jeppesen SS, Nilsson AC, Østerlev S, Vestergaard H, et al. Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer. Cancer Cell. 2021;39(8):1034-6.Search in Google Scholar
Bange EM, Han NA, Wileyto P, Kim JY, Gouma S, Robinson J, et al. CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer. Nat Med. 2021;27(7):1280-9.Search in Google Scholar
Mairhofer M, Kausche L, Kaltenbrunner S, Ghanem R, Stegemann M, Klein K, et al. Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer. Cancer Cell. 2021;39(9):1171-2.Search in Google Scholar
Lo Sasso B, Giglio RV, Vidali M, Scazzone C, Bivona G, Gambino CM, et al. Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine. Diagnostics. 2021; 11(7):1135.Search in Google Scholar
Profil Orcid